Dramatic hyperleukocytosis after treatment of myelodysplastic syndrome with pegfilgrastim and darbepoetin-alfa

Ann Hematol. 2008 Jan;87(1):77-8. doi: 10.1007/s00277-007-0364-9. Epub 2007 Aug 21.

Authors

Bjoern-N Heydrich, Robert Schoch, Heinz-August Horst, Michael Kneba

PMID: 17710399
DOI: 10.1007/s00277-007-0364-9

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Darbepoetin alfa
Drug Therapy, Combination
Erythropoietin / adverse effects
Erythropoietin / analogs & derivatives*
Erythropoietin / therapeutic use
Filgrastim
Granulocyte Colony-Stimulating Factor / adverse effects*
Granulocyte Colony-Stimulating Factor / therapeutic use*
Humans
Leukocytosis / chemically induced*
Male
Myelodysplastic Syndromes / drug therapy*
Polyethylene Glycols
Recombinant Proteins

Substances

Recombinant Proteins
Erythropoietin
Granulocyte Colony-Stimulating Factor
Darbepoetin alfa
pegfilgrastim
Polyethylene Glycols
Filgrastim